Rimona S. Weil

6.1k total citations · 3 hit papers
83 papers, 3.1k citations indexed

About

Rimona S. Weil is a scholar working on Neurology, Cognitive Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rimona S. Weil has authored 83 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Neurology, 35 papers in Cognitive Neuroscience and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rimona S. Weil's work include Parkinson's Disease Mechanisms and Treatments (36 papers), Functional Brain Connectivity Studies (14 papers) and Neurological disorders and treatments (12 papers). Rimona S. Weil is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (36 papers), Functional Brain Connectivity Studies (14 papers) and Neurological disorders and treatments (12 papers). Rimona S. Weil collaborates with scholars based in United Kingdom, United States and Italy. Rimona S. Weil's co-authors include Geraint Rees, Stephen M. Fleming, Raymond J. Dolan, Andrew J. Lees, Anette Schrag, Zoltán Nagy, Angeliki Zarkali, Huw R. Morris, Jason D. Warren and Louise‐Ann Leyland and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Rimona S. Weil

77 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relating Introspective Accuracy to Individual Differences in Brain Structure

2010 568 citations Stephen M. Fleming, Rimona S. Weil et al. Science profile →
Visual dysfunction in Parkinson’s disease

2016 308 citations Rimona S. Weil, Anette Schrag et al. Brain profile →
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches

2022 145 citations Rimona S. Weil et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rimona S. Weil United Kingdom	28	1.4k	1.1k	403	351	306	83	3.1k
Matteo Pardini Italy	35	1.3k 0.9×	933 0.9×	503 1.2×	884 2.5×	389 1.3×	169	4.0k
Francesca Baglio Italy	32	1.0k 0.7×	620 0.6×	582 1.4×	763 2.2×	214 0.7×	177	3.3k
Gian Luigi Lenzi Italy	29	1.3k 0.9×	685 0.6×	363 0.9×	713 2.0×	397 1.3×	74	3.8k
Fabrizio Piras Italy	36	1.6k 1.1×	647 0.6×	770 1.9×	958 2.7×	375 1.2×	111	3.5k
Penny A. MacDonald Canada	27	1.3k 0.9×	621 0.6×	165 0.4×	241 0.7×	404 1.3×	65	2.7k
Patrice Péran France	33	1.2k 0.9×	1.2k 1.2×	1.1k 2.7×	647 1.8×	197 0.6×	140	3.7k
Karsten Mueller Germany	40	1.9k 1.3×	659 0.6×	718 1.8×	857 2.4×	413 1.3×	123	4.5k
Adam G. Thomas United Kingdom	21	1.0k 0.7×	438 0.4×	451 1.1×	182 0.5×	160 0.5×	46	2.2k
Mojtaba Zarei Iran	33	1.6k 1.1×	824 0.8×	1.1k 2.8×	737 2.1×	438 1.4×	91	3.4k
Marcus Heldmann Germany	27	1.1k 0.8×	596 0.6×	205 0.5×	183 0.5×	361 1.2×	122	2.2k

Countries citing papers authored by Rimona S. Weil

Since Specialization

Citations

This map shows the geographic impact of Rimona S. Weil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rimona S. Weil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rimona S. Weil more than expected).

Fields of papers citing papers by Rimona S. Weil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rimona S. Weil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rimona S. Weil. The network helps show where Rimona S. Weil may publish in the future.

Co-authorship network of co-authors of Rimona S. Weil

This figure shows the co-authorship network connecting the top 25 collaborators of Rimona S. Weil. A scholar is included among the top collaborators of Rimona S. Weil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rimona S. Weil. Rimona S. Weil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhome, Rohan, George E. Thomas, Angeliki Zarkali, et al.. (2025). Quantitative susceptibility mapping reveals differences between subtypes of Lewy body dementia. Brain. 149(3). 1058–1069.

Zarkali, Angeliki, et al.. (2025). Evidence for divergent cortical organisation in Parkinson’s disease and Lewy Body Dementia. Nature Communications. 16(1). 11623–11623.

Zarkali, Angeliki, George E. Thomas, Ross W. Paterson, et al.. (2025). Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space ( DTI ‐ ALPS) , is Linked to Poor Cognitive Outcomes in Parkinson's Disease. Movement Disorders. 40(11). 2367–2380.

Weil, Rimona S., Judith Breuer, Maria C. Rodriguez‐Barradas, et al.. (2024). Herpes Zoster and Risk of Incident Parkinson's Disease in US Veterans: A Matched Cohort Study. Movement Disorders. 39(2). 438–444. 4 indexed citations

Zarkali, Angeliki, Peter McColgan, Amanda Heslegrave, et al.. (2024). Neuroimaging and plasma evidence of early white matter loss in Parkinson’s disease with poor outcomes. Brain Communications. 6(3). fcae130–fcae130. 6 indexed citations

Thomas, George E., et al.. (2024). Longitudinal Associations of Magnetic Susceptibility with Clinical Severity in Parkinson's Disease. Movement Disorders. 39(3). 546–559. 14 indexed citations

Bhome, Rohan, George E. Thomas, Angeliki Zarkali, & Rimona S. Weil. (2023). Structural and Functional Imaging Correlates of Visual Hallucinations in Parkinson’s Disease. Current Neurology and Neuroscience Reports. 23(6). 287–299. 7 indexed citations

Peng, Yuwei, Christine Girges, Thomas Foltynie, et al.. (2023). Computer vision quantification of whole-body Parkinsonian bradykinesia using a large multi-site population. npj Parkinson s Disease. 9(1). 35 indexed citations

Thomas, George E., et al.. (2022). Changes in both top-down and bottom-up effective connectivity drive visual hallucinations in Parkinson’s disease. Brain Communications. 5(1). fcac329–fcac329. 24 indexed citations

10.

ffytche, Dominic, Simon J.G. Lewis, Phil Hyu Lee, et al.. (2022). Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinations. Nature Communications. 13(1). 519–519. 22 indexed citations

11.

Zarkali, Angeliki, Andrea I. Luppi, Emmanuel A. Stamatakis, et al.. (2022). Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease. Communications Biology. 5(1). 928–928. 18 indexed citations

12.

Thomas, George E., Angeliki Zarkali, Mina Ryten, et al.. (2021). Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease. Brain. 144(6). 1787–1798. 72 indexed citations

13.

Zarkali, Angeliki, Peter McColgan, Louise‐Ann Leyland, et al.. (2021). Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson’s disease. Communications Biology. 4(1). 86–86. 52 indexed citations

14.

Oxtoby, Neil P., Louise‐Ann Leyland, Leon Aksman, et al.. (2021). Sequence of clinical and neurodegeneration events in Parkinson’s disease progression. Brain. 144(3). 975–988. 60 indexed citations

15.

Zarkali, Angeliki, Peter McColgan, Louise‐Ann Leyland, et al.. (2020). Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction. Neurology. 94(14). e1525–e1538. 47 indexed citations

16.

Zarkali, Angeliki, Peter McColgan, Mina Ryten, et al.. (2020). Differences in network controllability and regional gene expression underlie hallucinations in Parkinson’s disease. Brain. 143(11). 3435–3448. 35 indexed citations

17.

Bremner, F D, et al.. (2019). Visual tests predict dementia risk in Parkinson's disease. UCL Discovery (University College London). 4 indexed citations

18.

Weil, Rimona S., Anette Schrag, Jason D. Warren, et al.. (2016). Visual dysfunction in Parkinson’s disease. Brain. 139(11). 2827–2843. 308 indexed citations breakdown →

19.

Fleming, Stephen M., Rimona S. Weil, Zoltán Nagy, Raymond J. Dolan, & Geraint Rees. (2010). Relating Introspective Accuracy to Individual Differences in Brain Structure. Science. 329(5998). 1541–1543. 568 indexed citations breakdown →

20.

Weil, Rimona S., Jonathan Cohen, Ilaria Portarena, & M. Brada. (2006). Optimal dose of stereotactic radiosurgery for acoustic neuromas: a systematic review. British Journal of Neurosurgery. 20(4). 195–202. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact